Jeff Yass’s Edgewise Therapeutics EWTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$28.1M Buy
692,476
+686,784
+12,066% +$29.2M ﹤0.01% 2014
2026
Q2
$231K Sell
5,692
-20,982
-79% -$723K ﹤0.01% 11646
2026
Q1
$840K Sell
26,674
-43,522
-62% -$1.26M ﹤0.01% 8350
2025
Q4
$1.74M Buy
70,196
+24,561
+54% +$493K ﹤0.01% 5933
2025
Q3
$740K Sell
45,635
-69,635
-60% -$988K ﹤0.01% 8069
2025
Q2
$1.51M Sell
115,270
-61,396
-35% -$885K ﹤0.01% 6424
2025
Q1
$3.89M Buy
176,666
+144,953
+457% +$3.8M ﹤0.01% 4129
2024
Q4
$847K Sell
31,713
-168,787
-84% -$5.37M ﹤0.01% 7382
2024
Q3
$5.35M Buy
200,500
+183,724
+1,095% +$3.65M ﹤0.01% 3485
2024
Q2
$302K Sell
16,776
-10,094
-38% -$176K ﹤0.01% 9434
2024
Q1
$490K Sell
26,870
-27,566
-51% -$438K ﹤0.01% 8562
2023
Q4
$596K Buy
+54,436
New +$382K ﹤0.01% 8233
2023
Q3
– Sell
-11,735
Closed -$90.9K – 12262
2023
Q2
$90.9K Sell
11,735
-5,150
-31% -$43.4K ﹤0.01% 11019
2023
Q1
$113K Buy
+16,885
New +$157K ﹤0.01% 11193

Other funds holding EWTX

Jeff Yass's EWTX Position: Q3 2026 in Review

Jeff Yass increased its Edgewise Therapeutics (EWTX) stake by 12,066% in Q3 2026, buying an estimated $29.2M and bringing the position to 692,476 shares worth $28.1M. The position accounts for ﹤0.01% of the portfolio, ranked #2014.

Jeff Yass first reported a position in EWTX in Q1 2023 and has held it in 14 quarters since. 249 funds tracked by Wall St. Rank hold EWTX as of Q3 2026.

  • Jeff Yass held 692,476 shares of Edgewise Therapeutics worth $28.1M as of Q3 2026.
  • Jeff Yass bought 686,784 Edgewise Therapeutics shares in Q3 2026, an estimated $29.2M.
  • Edgewise Therapeutics made up ﹤0.01% of Jeff Yass's portfolio in Q3 2026, its #2014 holding.
  • Jeff Yass first reported a position in Edgewise Therapeutics in Q1 2023 and has held it in 14 quarters since.
  • 249 funds tracked by Wall St. Rank held Edgewise Therapeutics as of Q3 2026.

Based on Susquehanna International Group's 13F filing for Q3 2026, filed 16 Nov 2026.